← Eichor
Study identifier: NCT06839768 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Safety and Efficacy of MILEP Versus Standard EEP

Condition: Benign Prostate Hypertrophy(BPH) · LUTS(Lower Urinary Tract Symptoms)  ·  Sponsor: Sechenov University

PhaseNA
Planned participants340
Who can joinMale, 18 Years to 85 Years
Healthy volunteersNo

About this study

Endoscopic enucleation of the prostate (EEP) is a standard treatment for benign prostatic hyperplasia (BPH), with modifications such as MiLEP that utilizes smaller instruments. The reduced resectoscope diameter in MiLEP may help decrease rates of stress urinary incontinence (SUI) and urethral strictures. Objective: to compare the efficacy and safety of MiLEP and standard EEP with a thulium fiber laser (TFL).

This description comes directly from the study's public registry record.

Talk to the study team

Vladislav Petov, Associate Professor, urologist  ·  +7 925 351 75 49  ·  pettow@mail.ru

Always discuss trial participation with your own doctor first.

Locations (1)

Institute for Urology and Reproductive Health, Sechenov UniversityMoscow, RussiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06839768